| Title: | Identification and comparison of plasma metabolomics signatures for common types of gastrointestinal cancer |
| Lead Institution: | Nanjing Medical University |
| Principal investigator: | Dr Dong Hang |
Application 74073
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Gastrointestinal (GI) cancer constitutes a major part of the cancer incidence and mortality statistics worldwide. However, the biological mechanisms underlying GI carcinogenesis remains largely unknown. Although metabolic disturbances have been proposed to play a critical role in the development of GI cancer, it is unclear about which metabolites are involved and whether they can be used as biomarkers for predicting cancer risk. Therefore, based on UK Biobank, we aim to identify metabolites associated with GI cancer and to evaluate the risk prediction ability of the identified metabolites for GI cancer beyond known risk factors. We will spend about 2 years on the analyses. This project will provide significant insight into molecular mechanisms of GI cancer and identify novel biomarkers for its tailored prevention.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 14530 | Plasma metabolomic signature of a proinflammatory diet in relation to breast cancer risk: a prospective cohort study | Miao Long (+11) | 2025 | American Journal of Clinical Nutrition |
Enabling scientific discoveries that improve human health